董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Chaim Indig | 男 | CEO, Director | 44 | 760.45万美元 | 未持股 | 2023-05-17 |
| Michael Weintraub | 男 | Chair, Director | 64 | 38.50万美元 | 未持股 | 2023-05-17 |
| Mark Smith | 男 | Director | 71 | 24.13万美元 | 未持股 | 2023-05-17 |
| Ramin Sayar | 男 | Director | 50 | 22.67万美元 | 未持股 | 2023-05-17 |
| Edward L. Cahill | 男 | Director | 70 | 22.87万美元 | 未持股 | 2023-05-17 |
| Lainie Goldstein | 女 | Director | 55 | 23.12万美元 | 未持股 | 2023-05-17 |
| Gillian Munson | 女 | Director | 52 | 25.25万美元 | 未持股 | 2023-05-17 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Chaim Indig | 男 | CEO, Director | 44 | 760.45万美元 | 未持股 | 2023-05-17 |
| Evan Roberts | 男 | Chief Operating Officer | 44 | 394.51万美元 | 未持股 | 2023-05-17 |
| David Linetsky | 男 | Senior Vice President, Life Sciences | 43 | 392.22万美元 | 未持股 | 2023-05-17 |
| Michael J. Davidoff | 男 | Senior Vice President, Payer Solutions | 50 | 284.32万美元 | 未持股 | 2023-05-17 |
| Amy Beth VanDuyn | 女 | Senior Vice President, Human Resources | 50 | 未披露 | 未持股 | 2023-05-17 |
| Balaji Gandhi | 男 | Chief Financial Officer | 49 | 未披露 | 未持股 | 2023-05-17 |
| Allison Hoffman | 女 | General Counsel and Secretary | 52 | 391.70万美元 | 未持股 | 2023-05-17 |
董事简历
中英对照 | 中文 | 英文- Chaim Indig
-
自2005年1月成立以来，Chaim Indig一直担任我们的首席执行官和董事会成员。在共同创立Phreesia之前，Indig先生领导分析软件公司SpotFire，Inc.成功引入药品营销领域。英迪格曾入围2011年安永企业家奖（Ernst&Young&；S&；8220；Entrepreneur of the Year&；8221；），并作为梦百合创新者入选《斯坦福社会创新评论》（Stanford Social Innovation Review）。
Chaim Indig,has served as Phreesia's Chief Executive Officer and a member of its Board since co-founding the Company in 2005. Mr. Indig has helped shape the healthcare experience and improve outcomes for patients, providers and staff. Under his leadership, Phreesia has established a broad national footprint, developed strategic partnerships with some of the world's largest healthcare companies, and earned accolades for the Company's role in helping to make care more efficient and patient-centered. He also led Phreesia through its initial public offering in 2019 and was named one of The Software Report's Top 50 SaaS CEOs in 2021. Prior to co-founding Phreesia, Mr. Indig spearheaded the introduction of the analytics software company, Spotfire, Inc., into the pharmaceutical marketing space. - 自2005年1月成立以来，Chaim Indig一直担任我们的首席执行官和董事会成员。在共同创立Phreesia之前，Indig先生领导分析软件公司SpotFire，Inc.成功引入药品营销领域。英迪格曾入围2011年安永企业家奖（Ernst&Young&；S&；8220；Entrepreneur of the Year&；8221；），并作为梦百合创新者入选《斯坦福社会创新评论》（Stanford Social Innovation Review）。
- Chaim Indig,has served as Phreesia's Chief Executive Officer and a member of its Board since co-founding the Company in 2005. Mr. Indig has helped shape the healthcare experience and improve outcomes for patients, providers and staff. Under his leadership, Phreesia has established a broad national footprint, developed strategic partnerships with some of the world's largest healthcare companies, and earned accolades for the Company's role in helping to make care more efficient and patient-centered. He also led Phreesia through its initial public offering in 2019 and was named one of The Software Report's Top 50 SaaS CEOs in 2021. Prior to co-founding Phreesia, Mr. Indig spearheaded the introduction of the analytics software company, Spotfire, Inc., into the pharmaceutical marketing space.
- Michael Weintraub
-
Michael Weintraub自2005年1月以来一直担任创始董事长和董事会成员。Weintraub先生自2019年4月起担任梦百合企业软件私募股权公司Ardan Equity Partners，LLC的联合创始人兼管理合伙人。此前，Weintraub先生于2017年至2018年担任Optum Venture Management LLC（一家专注于数字健康创新的公司）的管理合伙人。Weintraub从2008年到2013年担任HuMedica，Inc.（一家人口健康管理和大数据公司）联合创始人和首席执行官。HuMedica，Inc.于2013年被UnitedHealth Group（UHG）收购后，Weintraub先生于2013年至2017年担任UHG Optum Analytics的总裁兼首席执行官。在创办HuMedica，Inc.之前，Weintraub先生曾担任梦百合投资银行Leerink Partners LLC的高级常务董事。Weintraub从2001年到2005年还担任Pharmetrics，Inc.（一家梦百合信息公司，2005年被IMS Health，Inc.（现为IQVIA HoldingsInc.）收购）首席执行官。Weintraub先生目前担任全球梦百合公司Broadreach梦百合有限责任公司、Holmusk有限公司和Corrona有限责任公司的董事会主席，Corrona有限责任公司是肿瘤分析公司、Newfire有限责任公司和学院糖尿病网络的董事会成员，以及波士顿儿童医院（Boston Children’；s Hospital）创新和数字健康加速器的顾问委员会成员。作为哈佛商学院（Harvard Business School）的常驻企业家，韦特劳布还专注于梦百合创新。Weintraub先生在马萨诸塞州波士顿的布兰迪斯大学（Brandeis University）获得经济学学士学位，并在马萨诸塞州波士顿的哈佛商学院（Harvard Business School）获得工商管理硕士学位。
Michael Weintraub,has served as Founding Chair and as a member of Phreesia, Inc. Board since 2005. Mr. Weintraub serves as Co-Founder and Managing Partner of Ardan Equity, a healthcare enterprise software private equity firm, since April 2019. Previously, Mr. Weintraub served as Managing Partner of Optum Venture Management LLC, a company focused on digital health innovation, from 2017 to 2018. Mr. Weintraub was Co-Founder and Chief Executive Officer of Humedica, Inc., a population health management and big data company, from 2008 until 2013. After Humedica, Inc. was acquired by UnitedHealth Group, or UHG, in 2013, Mr. Weintraub served as President and Chief Executive Officer of Optum Analytics, UHG, from 2013 until 2017. Prior to launching Humedica, Inc., Mr. Weintraub served as Senior Managing Director at Leerink Partners LLC, a healthcare investment bank. Mr. Weintraub also served as Chief Executive Officer of PharMetrics, Inc. from 2001 until 2005, a healthcare informatics company, which was acquired by IMS Health, Inc., now IQVIA Holdings Inc., in 2005. Mr. Weintraub currently serves as Chair of the board of directors of BroadReach Healthcare, LLC, a healthcare company and Holmusk Ltd, a data analytics and health technology company, and as a member of the board of directors of CorEvitas, LLC, Forsyth Health, OncoHealth, Newfire, LLC and The Diabetes Link, formerly known as The College Diabetes Network, and as an advisory board member of the Innovation and Digital Health Accelerator at Boston Children's Hospital. Mr. Weintraub also focuses on healthcare innovation as an Entrepreneur in Residence at Harvard Business School. Mr. Weintraub received his bachelor's degree in Economics from Brandeis University and an M.B.A. from Harvard Business School. - Michael Weintraub自2005年1月以来一直担任创始董事长和董事会成员。Weintraub先生自2019年4月起担任梦百合企业软件私募股权公司Ardan Equity Partners，LLC的联合创始人兼管理合伙人。此前，Weintraub先生于2017年至2018年担任Optum Venture Management LLC（一家专注于数字健康创新的公司）的管理合伙人。Weintraub从2008年到2013年担任HuMedica，Inc.（一家人口健康管理和大数据公司）联合创始人和首席执行官。HuMedica，Inc.于2013年被UnitedHealth Group（UHG）收购后，Weintraub先生于2013年至2017年担任UHG Optum Analytics的总裁兼首席执行官。在创办HuMedica，Inc.之前，Weintraub先生曾担任梦百合投资银行Leerink Partners LLC的高级常务董事。Weintraub从2001年到2005年还担任Pharmetrics，Inc.（一家梦百合信息公司，2005年被IMS Health，Inc.（现为IQVIA HoldingsInc.）收购）首席执行官。Weintraub先生目前担任全球梦百合公司Broadreach梦百合有限责任公司、Holmusk有限公司和Corrona有限责任公司的董事会主席，Corrona有限责任公司是肿瘤分析公司、Newfire有限责任公司和学院糖尿病网络的董事会成员，以及波士顿儿童医院（Boston Children’；s Hospital）创新和数字健康加速器的顾问委员会成员。作为哈佛商学院（Harvard Business School）的常驻企业家，韦特劳布还专注于梦百合创新。Weintraub先生在马萨诸塞州波士顿的布兰迪斯大学（Brandeis University）获得经济学学士学位，并在马萨诸塞州波士顿的哈佛商学院（Harvard Business School）获得工商管理硕士学位。
- Michael Weintraub,has served as Founding Chair and as a member of Phreesia, Inc. Board since 2005. Mr. Weintraub serves as Co-Founder and Managing Partner of Ardan Equity, a healthcare enterprise software private equity firm, since April 2019. Previously, Mr. Weintraub served as Managing Partner of Optum Venture Management LLC, a company focused on digital health innovation, from 2017 to 2018. Mr. Weintraub was Co-Founder and Chief Executive Officer of Humedica, Inc., a population health management and big data company, from 2008 until 2013. After Humedica, Inc. was acquired by UnitedHealth Group, or UHG, in 2013, Mr. Weintraub served as President and Chief Executive Officer of Optum Analytics, UHG, from 2013 until 2017. Prior to launching Humedica, Inc., Mr. Weintraub served as Senior Managing Director at Leerink Partners LLC, a healthcare investment bank. Mr. Weintraub also served as Chief Executive Officer of PharMetrics, Inc. from 2001 until 2005, a healthcare informatics company, which was acquired by IMS Health, Inc., now IQVIA Holdings Inc., in 2005. Mr. Weintraub currently serves as Chair of the board of directors of BroadReach Healthcare, LLC, a healthcare company and Holmusk Ltd, a data analytics and health technology company, and as a member of the board of directors of CorEvitas, LLC, Forsyth Health, OncoHealth, Newfire, LLC and The Diabetes Link, formerly known as The College Diabetes Network, and as an advisory board member of the Innovation and Digital Health Accelerator at Boston Children's Hospital. Mr. Weintraub also focuses on healthcare innovation as an Entrepreneur in Residence at Harvard Business School. Mr. Weintraub received his bachelor's degree in Economics from Brandeis University and an M.B.A. from Harvard Business School.
- Mark Smith
-
Mark Smith自2018年10月以来一直担任我们的董事会成员。Smith博士目前是University of California at San Francisco临床医学教授。2015年至2019年，他担任医疗保健支付学习和行动网络指导委员会联合主席。在此之前，从1996年到2013年，史密斯博士是加州梦百合基金会（California Foundation，Inc.）的创始总裁兼前首席执行官，该基金会是一家专注于改善个人健康的慈善组织。Smith博士担任Teladoc Health，Inc.、英联邦基金、梦百合改善研究所、Prealize和Concerto梦百合，Inc.的董事会成员。史密斯博士在马萨诸塞州剑桥市的哈佛学院获得非裔美国人研究的学士学位，在北卡罗来纳州教堂山的北卡罗来纳大学获得医学博士学位，在宾夕法尼亚州费城的宾夕法尼亚大学获得梦百合管理的工商管理硕士学位。
Mark Smith,has served as a member of Phreesia, Inc. Board since October 2018. Dr. Smith is currently Professor of Clinical Medicine at the University of California at San Francisco. From 2015 to 2019 he served as co-chair of the Guiding Committee of the Health Care Payment Learning and Action Network. Previously, Dr. Smith was the founding President and former Chief Executive Officer of the California Healthcare Foundation, Inc., a philanthropic organization focused on improving the health of individuals, from 1996 to 2013. Dr. Smith serves as a member of the board of directors of Jazz Pharmaceuticals plc, Teladoc Health, Inc., the Commonwealth Fund, and Prealize. Dr. Smith earned his B.A. degree in Afro-American Studies from Harvard College, his M.D. from the University of North Carolina at Chapel Hill, and his M.B.A. in Healthcare Administration from the Wharton School at the University of Pennsylvania. - Mark Smith自2018年10月以来一直担任我们的董事会成员。Smith博士目前是University of California at San Francisco临床医学教授。2015年至2019年，他担任医疗保健支付学习和行动网络指导委员会联合主席。在此之前，从1996年到2013年，史密斯博士是加州梦百合基金会（California Foundation，Inc.）的创始总裁兼前首席执行官，该基金会是一家专注于改善个人健康的慈善组织。Smith博士担任Teladoc Health，Inc.、英联邦基金、梦百合改善研究所、Prealize和Concerto梦百合，Inc.的董事会成员。史密斯博士在马萨诸塞州剑桥市的哈佛学院获得非裔美国人研究的学士学位，在北卡罗来纳州教堂山的北卡罗来纳大学获得医学博士学位，在宾夕法尼亚州费城的宾夕法尼亚大学获得梦百合管理的工商管理硕士学位。
- Mark Smith,has served as a member of Phreesia, Inc. Board since October 2018. Dr. Smith is currently Professor of Clinical Medicine at the University of California at San Francisco. From 2015 to 2019 he served as co-chair of the Guiding Committee of the Health Care Payment Learning and Action Network. Previously, Dr. Smith was the founding President and former Chief Executive Officer of the California Healthcare Foundation, Inc., a philanthropic organization focused on improving the health of individuals, from 1996 to 2013. Dr. Smith serves as a member of the board of directors of Jazz Pharmaceuticals plc, Teladoc Health, Inc., the Commonwealth Fund, and Prealize. Dr. Smith earned his B.A. degree in Afro-American Studies from Harvard College, his M.D. from the University of North Carolina at Chapel Hill, and his M.B.A. in Healthcare Administration from the Wharton School at the University of Pennsylvania.
- Ramin Sayar
-
Ramin Sayar，自2021年10月起担任Phreesia, Inc.董事会成员。Sayar先生是Sumo Logic, Inc.的首席执行官和董事会成员，Sumo Logic公司是一家软件公司，他自2014年12月以来一直在该公司任职。2010年4月至2014年12月，Sayar先生在软件虚拟化公司VMware，Inc.担任云管理业务部高级副总裁兼总经理。2006年11月至2010年4月，Sayar先生在软件开发公司惠普软件技术有限公司担任产品和战略副总裁。萨亚尔拥有加州大学圣巴巴拉分校的历史学学士学位和圣何塞州立大学的工商管理硕士学位。
Ramin Sayar,has served as a member of Phreesia, Inc. Board since October 2021. Mr. Sayar is the Chief Executive Officer and a member of the board of directors of Sumo Logic, Inc., a software company where he has served since December 2014. From April 2010 to December 2014, Mr. Sayar served as Senior Vice President and General Manager, Cloud Management Business Unit at VMware, Inc., a software virtualization company. From November 2006 to April 2010, Mr. Sayar served as Vice President of Products and Strategy at HP Software Technology Pvt. Ltd., a software development company. Mr. Sayar holds a B.A. in History from the University of California, Santa Barbara and an M.B.A. from San Jose State University. - Ramin Sayar，自2021年10月起担任Phreesia, Inc.董事会成员。Sayar先生是Sumo Logic, Inc.的首席执行官和董事会成员，Sumo Logic公司是一家软件公司，他自2014年12月以来一直在该公司任职。2010年4月至2014年12月，Sayar先生在软件虚拟化公司VMware，Inc.担任云管理业务部高级副总裁兼总经理。2006年11月至2010年4月，Sayar先生在软件开发公司惠普软件技术有限公司担任产品和战略副总裁。萨亚尔拥有加州大学圣巴巴拉分校的历史学学士学位和圣何塞州立大学的工商管理硕士学位。
- Ramin Sayar,has served as a member of Phreesia, Inc. Board since October 2021. Mr. Sayar is the Chief Executive Officer and a member of the board of directors of Sumo Logic, Inc., a software company where he has served since December 2014. From April 2010 to December 2014, Mr. Sayar served as Senior Vice President and General Manager, Cloud Management Business Unit at VMware, Inc., a software virtualization company. From November 2006 to April 2010, Mr. Sayar served as Vice President of Products and Strategy at HP Software Technology Pvt. Ltd., a software development company. Mr. Sayar holds a B.A. in History from the University of California, Santa Barbara and an M.B.A. from San Jose State University.
- Edward L. Cahill
-
Edward L. Cahill，曾担任Phreesia, Inc.的成员。2007年10月起担任董事会成员。自2000年5月以来，他担任HLM Venture Partners的管理合伙人，该公司投资于新兴医疗保健、商业服务和技术公司。从1995年6月到2000年5月，他是私人股本公司Cahill, Warnock & Company（现为Camden Partners Holding, LLC）的创始合伙人。在此之前，他是Alex, Brown & Sons, Inc.的董事总经理，在那里他从1986年到1995年领导该公司的医疗保健集团。他是Blue Rabbit Ventures, Inc.， Carevive Systems, Inc.和Persivia Inc.的董事会成员，也是Johns Hopkins Medicine, Johns Hopkins Health System的名誉受托人，以及Mercy Health Services的受托人。他曾担任许多上市和私人控股公司的董事会成员，包括但不限于Tandem Diabetes Care, Inc.、Masimo Corp.、Centene Corp.和TyRx, Inc.。他持有Williams College的学士学位和Yale University的公共和私人管理硕士学位。
Edward L. Cahill,has served as a member of Phreesia, Inc. Board since October 2007. Mr. Cahill serves as Managing Partner at HLM Venture Partners, which invests in emerging healthcare, business services, and technology companies, a position he has held since May 2000. From June 1995 until May 2000, Mr. Cahill was a Founding Partner of Cahill, Warnock & Company (now Camden Partners Holding, LLC), a private equity firm. Prior to that, Mr. Cahill was a Managing Director of Alex, Brown & Sons, Inc., where he headed the firm's Healthcare Group from 1986 through 1995. Mr. Cahill serves as a member of the board of directors of Blue Rabbit Ventures, Inc., Carevive Systems, Inc. and Persivia Inc. and serves as emeritus trustee of Johns Hopkins Medicine, Johns Hopkins Health System, and trustee at Mercy Health Services. Mr. Cahill previously served as a member of the board of directors of many public and privately held companies including but not limited to Tandem Diabetes Care, Inc., Masimo Corp., Centene Corp., and TyRx, Inc. Mr. Cahill holds a B.A. from Williams College and a Master of Public and Private Management degree from Yale University. - Edward L. Cahill，曾担任Phreesia, Inc.的成员。2007年10月起担任董事会成员。自2000年5月以来，他担任HLM Venture Partners的管理合伙人，该公司投资于新兴医疗保健、商业服务和技术公司。从1995年6月到2000年5月，他是私人股本公司Cahill, Warnock & Company（现为Camden Partners Holding, LLC）的创始合伙人。在此之前，他是Alex, Brown & Sons, Inc.的董事总经理，在那里他从1986年到1995年领导该公司的医疗保健集团。他是Blue Rabbit Ventures, Inc.， Carevive Systems, Inc.和Persivia Inc.的董事会成员，也是Johns Hopkins Medicine, Johns Hopkins Health System的名誉受托人，以及Mercy Health Services的受托人。他曾担任许多上市和私人控股公司的董事会成员，包括但不限于Tandem Diabetes Care, Inc.、Masimo Corp.、Centene Corp.和TyRx, Inc.。他持有Williams College的学士学位和Yale University的公共和私人管理硕士学位。
- Edward L. Cahill,has served as a member of Phreesia, Inc. Board since October 2007. Mr. Cahill serves as Managing Partner at HLM Venture Partners, which invests in emerging healthcare, business services, and technology companies, a position he has held since May 2000. From June 1995 until May 2000, Mr. Cahill was a Founding Partner of Cahill, Warnock & Company (now Camden Partners Holding, LLC), a private equity firm. Prior to that, Mr. Cahill was a Managing Director of Alex, Brown & Sons, Inc., where he headed the firm's Healthcare Group from 1986 through 1995. Mr. Cahill serves as a member of the board of directors of Blue Rabbit Ventures, Inc., Carevive Systems, Inc. and Persivia Inc. and serves as emeritus trustee of Johns Hopkins Medicine, Johns Hopkins Health System, and trustee at Mercy Health Services. Mr. Cahill previously served as a member of the board of directors of many public and privately held companies including but not limited to Tandem Diabetes Care, Inc., Masimo Corp., Centene Corp., and TyRx, Inc. Mr. Cahill holds a B.A. from Williams College and a Master of Public and Private Management degree from Yale University.
- Lainie Goldstein
-
Lainie Goldstein，2007年6月起，她担任公司首席财务官。她还监督投资关系。2003年11月至2007年6月，她担任公司财政高级副总裁。她在软件、娱乐、零售和服装行业有20多年的财政和商业经验，包括13年监督上市公司财政状况的经历。2003年11月加入公司之前，她在服装公司Nautica Enterprises, Inc.担任7年的财政职位，最近担任财政与商业发展副总裁。她是一名注册会计师。1990至加入Nautica Enterprises, Inc.， 她在Grant Thornton LLP.的审计与重组部门担任职位。
Lainie Goldstein,has been Chief Financial Officer of the Company since June 2007, and is responsible for overseeing Finance, Investor Relations and Corporate Communications. Ms. Goldstein previously served as the Company's Senior Vice President of Finance from November 2003. Ms. Goldstein also serves as a director and member of the audit committee of Phreesia, Inc. - Lainie Goldstein，2007年6月起，她担任公司首席财务官。她还监督投资关系。2003年11月至2007年6月，她担任公司财政高级副总裁。她在软件、娱乐、零售和服装行业有20多年的财政和商业经验，包括13年监督上市公司财政状况的经历。2003年11月加入公司之前，她在服装公司Nautica Enterprises, Inc.担任7年的财政职位，最近担任财政与商业发展副总裁。她是一名注册会计师。1990至加入Nautica Enterprises, Inc.， 她在Grant Thornton LLP.的审计与重组部门担任职位。
- Lainie Goldstein,has been Chief Financial Officer of the Company since June 2007, and is responsible for overseeing Finance, Investor Relations and Corporate Communications. Ms. Goldstein previously served as the Company's Senior Vice President of Finance from November 2003. Ms. Goldstein also serves as a director and member of the audit committee of Phreesia, Inc.
- Gillian Munson
-
Gillian Munson，曾担任Phreesia, Inc.的成员。自2019年5月起担任董事会成员。Munson女士目前担任Vimeo, Inc.（视频托管、分享和服务平台）的首席财务官（2022年4月以来）。从2021年10月到2022年3月，Munson女士担任One Medical（会员制初级保健实践）的首席财务官特别顾问。在此之前，她曾担任Iora Health, Inc.（一家医疗保健公司）的首席财务官（从2020年12月到2021年9月出售）。Munson女士此前曾担任Union Square Ventures的合伙人。在此之前，她曾担任XO Group Inc. （the Knot Inc.的母公司）的首席财务官、财务主管和秘书（2013年至2019年）。Munson女士还曾担任Symbol Technologies, LLC的业务发展副总裁，Morgan Stanley的执行董事和高级股票分析师，Hambrecht & Quist的股票研究助理。她目前担任Duolingo, Inc.和the St. Regis Foundation的董事会成员，之前担任Monster Worldwide, Inc.的董事会成员。Munson女士获得The Colorado College的政治学和经济学学士学位。
Gillian Munson,has served as a member of Phreesia, Inc. Board since May 2019. Ms. Munson currently serves as Chief Financial Officer of Vimeo, Inc., a video hosting, sharing and services platform, a position she has held since April 2022. Ms. Munson previously served as Special Advisor to the chief financial officer of One Medical, a membership-based primary care practice, from October 2021 to March 2022. Prior to that, Ms. Munson was Chief Financial Officer of Iora Health, Inc., a healthcare company, from December 2020 until its sale in September 2021. Ms. Munson previously served as a Partner at Union Square Ventures. Prior to that, she served as Chief Financial Officer, Treasurer and Secretary of XO Group Inc., the parent company of The Knot Inc., from 2013 until 2019. Ms. Munson also held previous roles of Vice President, Business Development at Symbol Technologies, LLC, Executive Director and Senior Equity Analyst at Morgan Stanley and Equity Research Associate at Hambrecht & Quist. She currently serves on the board of directors of Duolingo, Inc., and The St. Regis Foundation and previously served on the board of directors of Monster Worldwide, Inc. Ms. Munson earned her B.A. in Political Science and Economics from The Colorado College. - Gillian Munson，曾担任Phreesia, Inc.的成员。自2019年5月起担任董事会成员。Munson女士目前担任Vimeo, Inc.（视频托管、分享和服务平台）的首席财务官（2022年4月以来）。从2021年10月到2022年3月，Munson女士担任One Medical（会员制初级保健实践）的首席财务官特别顾问。在此之前，她曾担任Iora Health, Inc.（一家医疗保健公司）的首席财务官（从2020年12月到2021年9月出售）。Munson女士此前曾担任Union Square Ventures的合伙人。在此之前，她曾担任XO Group Inc. （the Knot Inc.的母公司）的首席财务官、财务主管和秘书（2013年至2019年）。Munson女士还曾担任Symbol Technologies, LLC的业务发展副总裁，Morgan Stanley的执行董事和高级股票分析师，Hambrecht & Quist的股票研究助理。她目前担任Duolingo, Inc.和the St. Regis Foundation的董事会成员，之前担任Monster Worldwide, Inc.的董事会成员。Munson女士获得The Colorado College的政治学和经济学学士学位。
- Gillian Munson,has served as a member of Phreesia, Inc. Board since May 2019. Ms. Munson currently serves as Chief Financial Officer of Vimeo, Inc., a video hosting, sharing and services platform, a position she has held since April 2022. Ms. Munson previously served as Special Advisor to the chief financial officer of One Medical, a membership-based primary care practice, from October 2021 to March 2022. Prior to that, Ms. Munson was Chief Financial Officer of Iora Health, Inc., a healthcare company, from December 2020 until its sale in September 2021. Ms. Munson previously served as a Partner at Union Square Ventures. Prior to that, she served as Chief Financial Officer, Treasurer and Secretary of XO Group Inc., the parent company of The Knot Inc., from 2013 until 2019. Ms. Munson also held previous roles of Vice President, Business Development at Symbol Technologies, LLC, Executive Director and Senior Equity Analyst at Morgan Stanley and Equity Research Associate at Hambrecht & Quist. She currently serves on the board of directors of Duolingo, Inc., and The St. Regis Foundation and previously served on the board of directors of Monster Worldwide, Inc. Ms. Munson earned her B.A. in Political Science and Economics from The Colorado College.
高管简历
中英对照 | 中文 | 英文- Chaim Indig
自2005年1月成立以来，Chaim Indig一直担任我们的首席执行官和董事会成员。在共同创立Phreesia之前，Indig先生领导分析软件公司SpotFire，Inc.成功引入药品营销领域。英迪格曾入围2011年安永企业家奖（Ernst&Young&；S&；8220；Entrepreneur of the Year&；8221；），并作为梦百合创新者入选《斯坦福社会创新评论》（Stanford Social Innovation Review）。
Chaim Indig,has served as Phreesia's Chief Executive Officer and a member of its Board since co-founding the Company in 2005. Mr. Indig has helped shape the healthcare experience and improve outcomes for patients, providers and staff. Under his leadership, Phreesia has established a broad national footprint, developed strategic partnerships with some of the world's largest healthcare companies, and earned accolades for the Company's role in helping to make care more efficient and patient-centered. He also led Phreesia through its initial public offering in 2019 and was named one of The Software Report's Top 50 SaaS CEOs in 2021. Prior to co-founding Phreesia, Mr. Indig spearheaded the introduction of the analytics software company, Spotfire, Inc., into the pharmaceutical marketing space.- 自2005年1月成立以来，Chaim Indig一直担任我们的首席执行官和董事会成员。在共同创立Phreesia之前，Indig先生领导分析软件公司SpotFire，Inc.成功引入药品营销领域。英迪格曾入围2011年安永企业家奖（Ernst&Young&；S&；8220；Entrepreneur of the Year&；8221；），并作为梦百合创新者入选《斯坦福社会创新评论》（Stanford Social Innovation Review）。
- Chaim Indig,has served as Phreesia's Chief Executive Officer and a member of its Board since co-founding the Company in 2005. Mr. Indig has helped shape the healthcare experience and improve outcomes for patients, providers and staff. Under his leadership, Phreesia has established a broad national footprint, developed strategic partnerships with some of the world's largest healthcare companies, and earned accolades for the Company's role in helping to make care more efficient and patient-centered. He also led Phreesia through its initial public offering in 2019 and was named one of The Software Report's Top 50 SaaS CEOs in 2021. Prior to co-founding Phreesia, Mr. Indig spearheaded the introduction of the analytics software company, Spotfire, Inc., into the pharmaceutical marketing space.
- Evan Roberts
Evan Roberts自2019年1月起担任我们的首席运营官。罗伯茨先生曾于2012年1月至2019年1月担任客户解决方案Vice President，并于2005年1月成立至2012年1月担任首席技术官。在共同创立Phreesia之前，Roberts先生是Spotfire，Inc.的高级销售工程师，在那里他成功地领导了分析软件公司进入药品营销领域。Roberts先生在马萨诸塞州波士顿的塔夫茨大学（Tufts University）获得计算机工程学士学位。
Evan Roberts,has served as Phreesia, Inc. Chief Operating Officer since January 2019. Mr. Roberts previously served as Vice President of Customer Solutions from January 2012 until January 2019, and as Phreesia, Inc. Chief Technology Officer from inception in January 2005 until January 2012. Mr. Roberts received his B.S. degree in Computer Engineering from Tufts University.- Evan Roberts自2019年1月起担任我们的首席运营官。罗伯茨先生曾于2012年1月至2019年1月担任客户解决方案Vice President，并于2005年1月成立至2012年1月担任首席技术官。在共同创立Phreesia之前，Roberts先生是Spotfire，Inc.的高级销售工程师，在那里他成功地领导了分析软件公司进入药品营销领域。Roberts先生在马萨诸塞州波士顿的塔夫茨大学（Tufts University）获得计算机工程学士学位。
- Evan Roberts,has served as Phreesia, Inc. Chief Operating Officer since January 2019. Mr. Roberts previously served as Vice President of Customer Solutions from January 2012 until January 2019, and as Phreesia, Inc. Chief Technology Officer from inception in January 2005 until January 2012. Mr. Roberts received his B.S. degree in Computer Engineering from Tufts University.
- David Linetsky
David Linetsky自2019年3月起担任生命科学高级副总裁，。他曾担任我们的Vice President、分析和见解（从2018年7月到2019年3月）、我们的Vice President、财务和分析（从2015年1月到2018年7月）、我们的分析主管（从2013年1月到2014年12月），以及我们的高级数学家（从2008年到2012年）。2008年之前，Linetsky从2005年到2008年担任Phreesia实习生和顾问。Linetsky先生在加拿大艾伯塔省埃德蒙顿的阿尔伯塔大学（University of Alberta）获得数学学士学位，并获得哲学硕士学位。纽约市立大学（City University of New York，New York）研究生中心数学和逻辑学位，在那里他也是数学和逻辑博士候选人。
David Linetsky,has served as Phreesia, Inc. Senior Vice President, Life Sciences since March 2019. He previously served as Phreesia, Inc. Vice President, Analytics and Insights from July 2018 to March 2019, Phreesia, Inc. Vice President, Finance and Analytics from January 2015 to July 2018, Phreesia, Inc. Director of Analytics from January 2013 to December 2014 and Phreesia, Inc. Senior Mathematician from 2008 to 2012. Prior to 2008, Mr. Linetsky served as an intern and consultant to Phreesia from 2005 to 2008. Mr. Linetsky received his B.S. degree in Mathematics from the University of Alberta and his M.Phil. degree in Mathematics and Logic from the Graduate Center of the City University of New York where he was also a Ph.D. candidate in Mathematics and Logic.- David Linetsky自2019年3月起担任生命科学高级副总裁，。他曾担任我们的Vice President、分析和见解（从2018年7月到2019年3月）、我们的Vice President、财务和分析（从2015年1月到2018年7月）、我们的分析主管（从2013年1月到2014年12月），以及我们的高级数学家（从2008年到2012年）。2008年之前，Linetsky从2005年到2008年担任Phreesia实习生和顾问。Linetsky先生在加拿大艾伯塔省埃德蒙顿的阿尔伯塔大学（University of Alberta）获得数学学士学位，并获得哲学硕士学位。纽约市立大学（City University of New York，New York）研究生中心数学和逻辑学位，在那里他也是数学和逻辑博士候选人。
- David Linetsky,has served as Phreesia, Inc. Senior Vice President, Life Sciences since March 2019. He previously served as Phreesia, Inc. Vice President, Analytics and Insights from July 2018 to March 2019, Phreesia, Inc. Vice President, Finance and Analytics from January 2015 to July 2018, Phreesia, Inc. Director of Analytics from January 2013 to December 2014 and Phreesia, Inc. Senior Mathematician from 2008 to 2012. Prior to 2008, Mr. Linetsky served as an intern and consultant to Phreesia from 2005 to 2008. Mr. Linetsky received his B.S. degree in Mathematics from the University of Alberta and his M.Phil. degree in Mathematics and Logic from the Graduate Center of the City University of New York where he was also a Ph.D. candidate in Mathematics and Logic.
- Michael J. Davidoff
MichaelJ.Davidoff自2019年1月起担任我们的营销和业务发展高级副总裁。Davidoff先生曾于2015年3月至2018年12月担任我们的营销和业务发展Vice President2014年1月至2015年2月担任公司业务发展Vice President2010年6月至2013年12月担任金融产品Vice President以及2008年2月至2010年5月的产品营销总监。在Phreesia之前，Davidoff先生在March of Dimes和Merck&Co.担任产品管理和研究职位。Davidoff先生在马萨诸塞州波士顿的波士顿学院（Boston College）获得生物物理学学士学位，并在明尼苏达州明尼阿波利斯的明尼苏达大学（University of Minnesota）获得政策与行政硕士学位。
Michael J. Davidoff,has served as Phreesia, Inc. Senior Vice President, Payer Solutions since February 2022. Mr. Davidoff previously served as Phreesia, Inc. Senior Vice President of Marketing and Business Development from January 2019 until January 2022; Vice President of Marketing and Business Development from March 2014 until December 2018, Vice President, Corporate Business Development from January 2014 until February 2015; Vice President of Financial Products from June 2010 until December 2013; and Director/Senior Manager of Product Marketing from February 2008 until May 2010. Mr. Davidoff received his B.S. in Biophysics from Boston College and his M.P.H. in Policy and Administration from the University of Minnesota.- MichaelJ.Davidoff自2019年1月起担任我们的营销和业务发展高级副总裁。Davidoff先生曾于2015年3月至2018年12月担任我们的营销和业务发展Vice President2014年1月至2015年2月担任公司业务发展Vice President2010年6月至2013年12月担任金融产品Vice President以及2008年2月至2010年5月的产品营销总监。在Phreesia之前，Davidoff先生在March of Dimes和Merck&Co.担任产品管理和研究职位。Davidoff先生在马萨诸塞州波士顿的波士顿学院（Boston College）获得生物物理学学士学位，并在明尼苏达州明尼阿波利斯的明尼苏达大学（University of Minnesota）获得政策与行政硕士学位。
- Michael J. Davidoff,has served as Phreesia, Inc. Senior Vice President, Payer Solutions since February 2022. Mr. Davidoff previously served as Phreesia, Inc. Senior Vice President of Marketing and Business Development from January 2019 until January 2022; Vice President of Marketing and Business Development from March 2014 until December 2018, Vice President, Corporate Business Development from January 2014 until February 2015; Vice President of Financial Products from June 2010 until December 2013; and Director/Senior Manager of Product Marketing from February 2008 until May 2010. Mr. Davidoff received his B.S. in Biophysics from Boston College and his M.P.H. in Policy and Administration from the University of Minnesota.
- Amy Beth VanDuyn
Amy Beth VanDuyn自2019年3月起担任我们的人力资源高级副总裁。她曾于2010年4月至2019年3月担任我们的人力资源Vice President。任职Phreesia公司之前，Vanduyn女士曾担任许多行业的人力资源领导职务，包括软件即服务、酒店和公共关系。Vanduyn女士在密歇根州东兰辛的密歇根州立大学（Michigan State University）获得酒店业工商管理学士学位。
Amy Beth VanDuyn,has served as Phreesia, Inc. Senior Vice President of Human Resources since March 2019. She previously served as Phreesia, Inc. Vice President of Human Resources from April 2010 until March 2019. Ms. VanDuyn received her B.A. degree in Hospitality Business from Michigan State University.- Amy Beth VanDuyn自2019年3月起担任我们的人力资源高级副总裁。她曾于2010年4月至2019年3月担任我们的人力资源Vice President。任职Phreesia公司之前，Vanduyn女士曾担任许多行业的人力资源领导职务，包括软件即服务、酒店和公共关系。Vanduyn女士在密歇根州东兰辛的密歇根州立大学（Michigan State University）获得酒店业工商管理学士学位。
- Amy Beth VanDuyn,has served as Phreesia, Inc. Senior Vice President of Human Resources since March 2019. She previously served as Phreesia, Inc. Vice President of Human Resources from April 2010 until March 2019. Ms. VanDuyn received her B.A. degree in Hospitality Business from Michigan State University.
- Balaji Gandhi
Balaji Gandhi，自2023年3月起担任Phreesia, Inc.首席财务官。在此之前，他自2021年2月起担任Phreesia, Inc.投资者关系高级副总裁，并于2019年7月至2021年1月担任投资者关系副总裁。从2017年7月至2019年6月，甘地先生担任Madaket Inc.的首席财务官，该公司是一家基于云的医疗保健软件即服务公司。甘地先生在罗切斯特大学获得学士学位，并在乔治华盛顿大学获得卫生服务管理硕士学位，卫生政策分析。
Balaji Gandhi,has served as Phreesia, Inc. Chief Financial Officer since March 2023. Prior to that, he served as Phreesia, Inc. SVP, Investor Relations since February 2021, and he previously served as Vice President, Investor Relations from July 2019 to January 2021. From July 2017 until June 2019, Mr. Gandhi served as Chief Financial Officer of Madaket Inc., a cloud-based healthcare software-as-a-service company. Mr. Gandhi received his bachelor's degree from the University of Rochester and received his Master of Health Services Administration, Health Policy Analysis from The George Washington University.- Balaji Gandhi，自2023年3月起担任Phreesia, Inc.首席财务官。在此之前，他自2021年2月起担任Phreesia, Inc.投资者关系高级副总裁，并于2019年7月至2021年1月担任投资者关系副总裁。从2017年7月至2019年6月，甘地先生担任Madaket Inc.的首席财务官，该公司是一家基于云的医疗保健软件即服务公司。甘地先生在罗切斯特大学获得学士学位，并在乔治华盛顿大学获得卫生服务管理硕士学位，卫生政策分析。
- Balaji Gandhi,has served as Phreesia, Inc. Chief Financial Officer since March 2023. Prior to that, he served as Phreesia, Inc. SVP, Investor Relations since February 2021, and he previously served as Vice President, Investor Relations from July 2019 to January 2021. From July 2017 until June 2019, Mr. Gandhi served as Chief Financial Officer of Madaket Inc., a cloud-based healthcare software-as-a-service company. Mr. Gandhi received his bachelor's degree from the University of Rochester and received his Master of Health Services Administration, Health Policy Analysis from The George Washington University.
- Allison Hoffman
Allison Hoffman，女，自2013年8月以来担任本公司的副执行总裁、法律总顾问和公司秘书，她是于2012年12月加入该公司的。1999年6月-2012年9月期间在一家为法律和房地产行业提供专业新闻和信息咨询的主要供应商-ALM Media有限责任公司工作，2007年1月-2012年9月期间担任高级副总裁、首席法务官以及秘书；在2001年8月-2006年12月期间担任副总裁、法律总顾问和秘书职务；以及在1999年6月-2001年7月期间担任助理法律总顾问。1995年-1999年是Skadden、 Arps、Slate、Meagher和Flom LLP. 公司财政部门的助理；自2012年以来她还在Network-1 Technologies股份有限公司 （OTC Bulletin Board： NTIP）董事会任职，以及是薪酬委员会主席和审计委员会的成员。
Allison Hoffman,has served as General Counsel of Phreesia, Inc. (NYSE:PHR), a leading provider of software solutions that healthcare organizations Network-1 Technologies, Inc. e to manage the patient intake process. From January 2016 until August 2020, Ms. Hoffman served as Chief Legal Officer and Chief Administrative Officer at Intersection Parent, Inc..- Allison Hoffman，女，自2013年8月以来担任本公司的副执行总裁、法律总顾问和公司秘书，她是于2012年12月加入该公司的。1999年6月-2012年9月期间在一家为法律和房地产行业提供专业新闻和信息咨询的主要供应商-ALM Media有限责任公司工作，2007年1月-2012年9月期间担任高级副总裁、首席法务官以及秘书；在2001年8月-2006年12月期间担任副总裁、法律总顾问和秘书职务；以及在1999年6月-2001年7月期间担任助理法律总顾问。1995年-1999年是Skadden、 Arps、Slate、Meagher和Flom LLP. 公司财政部门的助理；自2012年以来她还在Network-1 Technologies股份有限公司 （OTC Bulletin Board： NTIP）董事会任职，以及是薪酬委员会主席和审计委员会的成员。
- Allison Hoffman,has served as General Counsel of Phreesia, Inc. (NYSE:PHR), a leading provider of software solutions that healthcare organizations Network-1 Technologies, Inc. e to manage the patient intake process. From January 2016 until August 2020, Ms. Hoffman served as Chief Legal Officer and Chief Administrative Officer at Intersection Parent, Inc..